FLT3 p.D835N
About
Gene context: FLT3
Biomarker Type: Somatic Variant
Present: True
Chromosome: 13
Start Position: 28592642
End Position: 28592642
Reference Allele: C
Alternate Allele: T
Cdna Change: c.2503G>A
Protein Change: p.D835N
Variant Annotation: Missense
Exon: 20
Rsid: rs121913488
Hgvsg: 13:g.28592642C>T
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | FLT3 p.D835N | Acute Lymphoid Leukemia | Gilteritinib | |
| FDA (1) | FLT3 p.D835N | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Midostaurin |